Aimmune Therapeu Shares Down 51.5% Since SmarTrend's Sell Call (AIMT)

SmarTrend identified a Downtrend for Aimmune Therapeu (NASDAQ:AIMT) on February 6th, 2020 at $29.72. In approximately 2 months, Aimmune Therapeu has returned 51.47% as of today's recent price of...